Adaütimmune LtdcancerFDA approves cell therapy for solid tumoursThe US Food & Drug Administration has granted accelerated approval to Adaptimmune’s Tecelra as the world’s first therapy with genetically engineered T cells to fight a solid tumour. more ➔
Armed Forces Institute of Pathology, AFIPvaccinesValneva licences LimmaTech’s Shigella vaccineFrench-Austrian vaccine maker Valneva SE has secured exclusive worldwide rights to commercialise LimmaTech Biologics AG’s S4V Shigella vaccine that will be tested in two Phase II trials starting in … more ➔
SIATfinancingBI Venture Funds invests in oncolytic bacteriaWith an investment of its venture arm (BI-VF), Boehringer Ingelheim underlines its committment to expand the reach of cancer immune therapies. The Series A financing in Chinese Synthetica Pioneering … more ➔
Maxwell Hamilton - wikipedia.orgpartnershipGSK and Flagship Pioneering ink US$7.2bn biobucks discovery dealAs one of the last Big Pharma companies, GlaxoSmithKline plc has inked a drug discovery licence option deal for up to 10 programmes with US-based biotech platform company supplier Flagship Pioneering … more ➔
Romain BuissonNovel FoodGourmey files first EU application for cell-based meatNot the German InFamily Foods subsidiary The Cultivated B, but Gourmey SAS, founded in Paris in 2019 by Antoine Davydoff, Nicolas Morin-Forest and Victor Sayous, has submitted the first EU authorisation … more ➔
Confo Therapeutics NVfinancingConfo Therapeutics closes €60m Series B financingBelgian GPCR specialist Confo Therapeutics NV has raised €60m in an Series B financing round led by Ackermans & van Haaren to advance clinical development of two clinical programmes and preclinical … more ➔
AC Immune SAAlzheimer’s DiseaseAC Immune bags FDA fast track designationSwiss AC Immune and its partner Janssen Pharmaceuticals Inc have been granted FDA Fast Track Designation for their active anti-pTau vaccine ACI-35.030/JNJ-2056 to treat Alzheimer’s disease. more ➔
Jan Kroenke, Charité BerlinMultiple myeloma New targets for incurable blood cancerA research consortium led by Charité in Berlin has found a protein pattern in 100 patients with the common blood cancer multiple myeloma and 38 healthy controls that independently identifies a poor … more ➔
Evotec SEgene therapySynaptixBio Ltd and Evotec SE expand collaborationEvotec SE is widening its 2022 R&D collaboration SynaptixBio Ltdi to optimise and identify new antisense oligonucleotides to treat children with H-ABC leukodystrophy, a rare genetic myelin synthesis … more ➔
UE 2024 - PEEU Commission PresidencyVon der Leyen: no mention of biotechnologyIn view of her confirmation as EU Commission President, biotech associations have reminded Ursula von der Leyen of her promise to strategically promote the sector with an EU Biotech Act 2025. more ➔
Adaütimmune Ltd
Armed Forces Institute of Pathology, AFIP
SIAT
Maxwell Hamilton - wikipedia.org
Romain Buisson
Confo Therapeutics NV
AC Immune SA
Jan Kroenke, Charité Berlin
Evotec SE
UE 2024 - PE